Cargando…
A case of non-small cell lung cancer with long-term response after re-challenge with nivolumab
A 76-year-old man was admitted to our hospital with cough and dyspnea. He was diagnosed with advanced lung cancer. Nivolumab was given as second-line treatment, cytotoxic chemotherapy was given as third-line treatment, and nivolumab re-challenge was given as fourth-line treatment. Thereafter, 41 che...
Autores principales: | Ito, Keima, Oguri, Tetsuya, Takeda, Norihisa, Fukumitsu, Kensuke, Fukuda, Satoshi, Kanemitsu, Yoshihiro, Tajiri, Tomoko, Ohkubo, Hirotsugu, Takemura, Masaya, Maeno, Ken, Ito, Yutaka, Niimi, Akio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6926357/ https://www.ncbi.nlm.nih.gov/pubmed/31890556 http://dx.doi.org/10.1016/j.rmcr.2019.100979 |
Ejemplares similares
-
Acute Eosinophilic Pneumonia Induced by Switching from Conventional Cigarette Smoking to Heated Tobacco Product Smoking
por: Tajiri, Tomoko, et al.
Publicado: (2020) -
Characteristics of the European Thoracic Society/American Thoracic Society severe asthma definition as a determinant of future use of biologics/bronchial thermoplasty
por: Nishiyama, Hirono, et al.
Publicado: (2022) -
Specific IgE Response and Omalizumab Responsiveness in Severe Allergic Asthma
por: Tajiri, Tomoko, et al.
Publicado: (2023) -
Residual Dyspnea May Predict Small Airways Dysfunction and Poor Responsiveness to Single-Inhaler Triple Therapy in Asthmatic Patients
por: Ito, Keima, et al.
Publicado: (2022) -
Erratum: Change original to “Characteristics of the European Thoracic Society/American Thoracic Society severe asthma definition as a determinant of future use of biologics/bronchial thermoplasty”
por: Nishiyama, Hirono, et al.
Publicado: (2022)